Hong Liang

29PUBLICATIONS
41CO-AUTHORS
Molecular targetsChemical and thermal processes in energy and combustionCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Oct 23, 2026
Oxoisoaporphine Half-Sandwich Osmium(II) Derivative: A Catalytic Trigger for Innate Tumor Chemoimmunotherapy.

|Aug 30, 2026
A triphenylphosphine-coordinated copper(I) complex with aggregation-induced emission characteristics for chemodynamic therapy.

|Jun 25, 2026
GPX4-Targeting Phenolato ZrIV Complexes Induce Ferroptosis and Lysosome-Dependent Cell Death for Immunotherapy of Chemoresistant Cancer.

|Jun 11, 2026
Pt(IV) Complexes Incorporating CDC25A/NF-κB Dual Inhibitory 1,4-Naphthoquinone Derivatives Trigger Multimodal Cell Death in A2780 Ovarian Cancer Cells.

|May 05, 2026
Discovery of a Novel Tetrahydro-β-Carboline Mcl-1 Inhibitor with Antitumor Activity and Capability to Overcome Cisplatin Resistance.

|Apr 21, 2026
Activation of Synergistic Ferroptosis and Apoptosis by a Cu(II) Complex through Concurrent Amplification of Endoplasmic Reticulum Stress and Mitochondrial Dysfunction.

Pageof 5

Frequent Collaborators

7 joint publications

Fu-Ping Huang

4 joint publications

Liangliang Zhang

4 joint publications

Changchun Wen

4 joint publications

Xing-Can Shen